can telehealth prescribe glp 1 GLP-1 Platforms Market, Growth and Forecast 2036 Telehealth booms as demand for

its got benefits for women too

Retrieved August 27, 2018

Mounjaro was approved by the FDA in 2022 as a GIP and GLP-1 receptor agonist for improving blood sugar control in adults with type 2 diabetes, and subsequent trials went on to evaluate its effects specifically on body weight in people with obesity or overweight

Also, considering the previous reports of improvement of psoriasis with GSHenhancer whey protein isolates, we hereby propose that this therapy may be used in future as an adjunct to the conventional first-line therapies in scalp psoriasis in cases of sub-optimal response with a better side-effect profile and an acceptable effect of skin lightening